Ambroxol Hydrochloride
Read this leaflet carefully because it contains important information for you..
This medicine should always be used exactly as described in this leaflet or as directed by your doctor, pharmacist, or nurse.
Ambrosol Teva syrup contains the active substance ambroxol hydrochloride, which acts as an expectorant and mucolytic (thins mucus). It increases the amount of mucus in the airways, reduces its viscosity, accelerates the transport of secretions in the airways, making it easier to cough up and relieving cough.
The indication for the use of Ambrosol Teva is acute and chronic respiratory diseases, characterized by difficulty in coughing up viscous bronchial secretions, such as:
Before starting treatment with Ambrosol Teva, you should consult your doctor:
Liquefaction of a large amount of secretions in immobilized patients and those in severe condition, as well as in small children, must be associated with its aspiration. In such patients, cough-suppressing medications should not be administered, as this may lead to accumulation of secretions in the airways.
Bronchial secretions should be thoroughly coughed up.
In patients with bronchial asthma, ambroxol may initially exacerbate cough.
Severe skin reactions associated with the use of ambroxol hydrochloride have been reported. If a rash appears (including changes in the mucous membranes, e.g., mouth, throat, nose, eyes, genitals), you should stop using Ambrosol Teva and immediately contact your doctor.
You should tell your doctor about all medicines you are currently taking or have recently taken, including those available without a prescription.
Ambroxol should not be administered simultaneously with cough medicines, such as codeine or medicines that suppress mucus production.
Ambroxol increases the penetration of some antibiotics (e.g., amoxicillin, cefuroxime, erythromycin, doxycycline) into lung tissue.
The medicine should be taken after a meal.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before using this medicine.
Pregnancy
The active substance of the medicine passes through the placental barrier. It is not recommended to use Ambrosol Teva during pregnancy, especially during the first three months of pregnancy.
Breastfeeding
Ambroxol hydrochloride passes into breast milk. It is not recommended to use Ambrosol Teva during breastfeeding.
There are no data on the effect of the medicine on the ability to drive and use machines.
No studies have been conducted on the effect of the medicine on the ability to drive and use machines.
Due to the presence of methyl parahydroxybenzoate and propyl parahydroxybenzoate, the medicine may cause allergic reactions (possible late reactions).
The medicine contains 150 mg of propylene glycol in 5 ml of syrup, which corresponds to 3.6 g of propylene glycol in 120 ml of syrup and 6 g of propylene glycol in 200 ml of syrup.
5 ml of syrup contains 2.25 g of sorbitol. Sorbitol is a source of fructose. If you or your child have been diagnosed with intolerance to some sugars or have been diagnosed with hereditary fructose intolerance, a rare genetic disorder in which the body does not break down fructose, you should consult your doctor before taking the medicine or giving it to your child. Sorbitol may cause gastrointestinal discomfort and may have a mild laxative effect. The energy value is 2.6 kcal/g of sorbitol.
Ambrosol Teva should always be used in accordance with the doctor's recommendations.
In case of doubt, you should consult your doctor or pharmacist.
The medicine should be taken orally, after a meal.
The medicine should not be taken directly before bedtime.
Adults and children over 12 years of age:
Initially, for 2 to 3 days, 30 mg of ambroxol hydrochloride (5 ml of syrup, i.e., 1 measuring spoon) should be taken 3 times a day; then the dose should be reduced to 30 mg (5 ml of syrup, i.e., 1 measuring spoon) 2 times a day.
Children from 6 to 12 years of age:
15 mg of ambroxol hydrochloride (2.5 ml of syrup, i.e., half a measuring spoon) 2 to 3 times a day.
Children from 2 to 6 years of age:
7.5 mg of ambroxol hydrochloride (1.25 ml of syrup, i.e., ¼ of a measuring spoon), 3 times a day.
Do not use in children without consulting a doctor.
If the treatment lasts longer than 7 to 14 days, the dose should be reduced.
If the symptoms worsen or do not improve after 4 to 5 days, you should contact your doctor.
The medicine does not contain sucrose.
If you feel that the effect of Ambrosol Teva is too strong or too weak, you should consult your doctor.
So far, there have been no specific symptoms of overdose in humans.
After taking a higher dose of Ambrosol Teva than recommended, the side effects listed in section 4 "Possible side effects" may occur. Symptomatic treatment is recommended.
In small children and patients with a weakened cough reflex (elderly, unconscious patients), it is necessary to ensure the removal of bronchial secretions from the airways.
In case of taking a higher dose of the medicine than recommended, you should immediately consult your doctor or pharmacist.
In case of missing a dose, you should take it as soon as possible, and then return to the recommended dosing schedule.
You should not take a double dose to make up for the missed dose.
In case of any further doubts related to the use of the medicine, you should consult your doctor.
Like all medicines, Ambrosol Teva can cause side effects, although not everybody gets them.
The following side effects may occur:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, https://smz.ezdrowie.gov.pl/
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store out of sight and reach of children.
Store at a temperature below 25°C. Protect from light.
Shelf life after first opening: 28 days.
Do not use Ambrosol Teva after the expiry date stated on the label and carton after "Expiry date:". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Ambrosol Teva, 30 mg/5 ml, is a clear syrup with a raspberry smell. The syrup is in a brown/orange glass bottle. The bottle contains 120 ml or 200 ml of syrup, is closed with an aluminum or polypropylene cap with a polyethylene foam seal and a polyethylene ring, or an HDPE cap with a polyethylene ring, and is placed in a cardboard box with a measuring spoon ( graduation 1.25; 2.5 and 5 ml).
Teva Pharmaceuticals Polska Sp. z o.o., ul. Emilii Plater 53, 00-113 Warsaw, tel.: (22) 345 93 00
Teva Operations Poland Sp. z o.o., ul. Mogilska 80, 31-546 Krakow
Balkanpharma Troyan AD, 1 Krayrechna Str., 5600 Troyan, Bulgaria
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.